References
- Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30(1): 27–34
- US Carvedilol Heart Failure Study Group. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 1996; 94(11): 2800–6
- Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of Carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997; 349(9049): 375–80
- Bristow MR, Gilbert EM, Packer M, et al. Effects of Carvedilol in elderly patients with chronic heart failure. (Abstr) Circulation 1997; 96: 1–577
References
- Bristow MR, Abraham WT, Yoshikawa T, et al. Second- and third- generation beta-blocking drugs in chronic heart failure. Cardiovasc Drugs Ther 1997; 11(Supp11): 291–6
- Hjalmarson A, Kneider M, Waagstein F. The role of beta-blockers in left ventricular dysfunction and heart failure. Drugs 1997; 54(4): 501–10
- Tan R, Philip P. Drugs and orthostatic hypotension in the elderly, part 1: role of drugs in etiology. Clin Geriatr (in press)
- Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26(2): 181–6